Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Health & wellness/
  4. Psyched about the eclipse? What you need to know to protect your eyes and watch it safely

Psyched about the eclipse? What you need to know to protect your eyes and watch it safely

On August 21, the U.S. will witness the first total eclipse of the sun in 40 years. In this video, get tips from a Johnson & Johnson expert on how to safeguard your eyes—and enjoy the one-of-a-kind celestial event.

On Monday, August 21, a total eclipse of the sun will be visible in parts of the continental U.S. for the first time in almost 40 years as the moon completely covers it—and observers in all states will experience at least a partial eclipse.

Because this phenomenon is so rare—the next total eclipse won’t occur in the U.S. until 2024—Americans across the country are clamoring to watch. And there’s no reason not to—as long as you do so safely: Even when blocked by the moon, the sun’s rays, both visible and invisible, can cause severe and permanent damage to the eyes.

So before you check out the eclipse, check out this video—featuring safe viewing tips from Johnson & Johnson Vision ultraviolet expert Cristina Schnider, O.D.


More from Johnson & Johnson

Moving toward a more personalized approach to treating depression

The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.

“Our goal is a solution for every bladder cancer patient”

Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.

Is this the end of one-size-fits-all treatments for depression?

Learn how Johnson & Johnson is working to better address the needs of the 7 in 10 people with depression whose treatments aren’t providing enough relief.